VMValerii N. Mineev

Valerii N. Mineev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valerii N. Mineev has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative characteristics of epigenetic regulation in rheumatoid arthritis and osteoarthritis

    by I. I. Nesterovich, M. S. Zhebeleva, V. N. Mineev

    Rheumatoid arthritis (RA) and osteoarthritis (OA) play an important role in the spectrum of modern human diseases. Currently, the pathogenesis of these disorders is considered regarding epigenetic regulation. Differences in the regulation of gene expression result in an altered immune response, leading to chronic joint inflammation. This review analyzes several epigenetic mechanisms associated with changes in proand anti-inflammatory factors that contribute to chronic immune-mediated inflammation. We conducted a literature search in the eLibrary, PubMed, CyberLeninka, and Frontiers medical databases using the search terms “epigenetics”, “epigenetic regulation”, “epigenetics of rheumatoid arthritis”, and “epigenetics of osteoarthritis”. Current data on the influence of epigenetic regulation on the development and prognosis of RA and OA are presented. The literature search covered the period from May 1994 to January 2025. Initially, 210 references were identified. Articles without freely available full text and studies unrelated to the objective of the review were excluded from the analysis. A total of 41 articles meeting the objective of this review were analyzed.

  • The role of Tas2R-signaling in the immunological response in bronchial asthma

    by M. A. Nyoma, R. G. Murkina, M. M. Yunusova, V. N. Mineev, М. А. Нёма, Р. Г. Муркина, М. М. Юнусова, В. Н. Минеев

    Research into the role of ectopic Tas2R bitter taste receptors in bronchial asthma encompasses a wide range of pathogenesis factors, including, primarily, their involvement in the development of broncho-obstructive syndrome. The role of the Tas2R signaling pathway in the immune response is less studied. This review analyzes currently available studies on the expression of Tas2R receptors on cells of both the innate immune response, including components such as physical barriers (skin and mucous membranes), and the adaptive immune response (dendritic cells, Tand B-lymphocytes). Data on the expression and primary functions mediated by Tas2R receptors in various cells of the immune system are presented. Tas2R signaling is generally involved in the regulation of immunological processes such as inflammation, including the release of cytokines from immune cells and the stimulation of phagocytosis. Tas2R receptors also participate in the recognition of various pathogens, allergens, and molecules such as quorum-sensing molecules secreted by Gram-negative bacteria. Tas2R receptors are considered promising pharmacological targets, particularly for difficult-to-control forms of bronchial asthma resistant to glucocorticoid therapy.

  • The Tas2R receptor signaling system – view of asthmologist

    by V. N. Mineev, M. A. Nyoma, R. G. Murkina

    Since 2010, studies have been published that have found expression of bitter taste receptors Tas2R (the so-called extralingual or ectopic) on bronchial smooth muscle cells, and then on many other cells outside their canonical localization, in particular, on inflammatory cells. It was found that activation of Tas2R receptors, contrary to the bronchoconstrictor effect initially expected by the authors, led to more pronounced (3 times) bronchodilation than activation by β 2 -agonists. Over the past 15 years since the discovery of ectopic expression of Tas2R receptors in the respiratory system, a number of research areas have emerged and are developing in this new field of bronchial asthma research. These areas include: I – study of the expression of Tas2R receptor subtypes on bronchial smooth muscle; II – studies of the molecular mechanisms of Tas2R-signaling; III – studies of Tas2R receptor expression on respiratory system cells (ciliated epithelium) and on cells involved in allergic inflammation (lymphocytes, mast cells, macrophages, etc.); IV – studies of Tas2R gene polymorphisms and their association with predisposition to bronchial asthma; V – studies of the role of soluble Tas2R receptors in bronchial asthma; VI – search for opportunities to use Tas2R receptor activation for targeted therapy of bronchial asthma. The review examines the main positions of research areas in the field of Tas2R-signaling in bronchial asthma and provides the main literature in this area. Despite the achievements in the treatment of bronchial asthma, it is known that control over the disease cannot always be achieved completely. It is concluded that, given the versatility of the effects of tas2r receptors in bronchial asthma (bronchodilation, decreased activity of allergic inflammation and bronchial hyperreactivity, effects on remodeling), these receptors are a promising candidate for the development of comprehensive therapy for bronchial asthma.

  • A concept of soluble receptors in bronchial asthma

    by V. N. Mineev, M. A. Nyoma, L. N. Sorokina, A. S. Pavlova, R. G. Murkina

    Functioning of soluble receptors, mainly soluble cytokine receptors, has been of interest to researchers since the last decade of the 20th century. Allergists’ interest in the issues of soluble receptors is relevant to our studies in the pathogenesis of bronchial asthma (BA), specifically, development of ectopic chemosensory signaling systems, including ectopic bitter taste receptors Tas2R, and signaling pathways of the Receptor for Advanced Glycation End products (RAGE). The expression of soluble receptors in BA was investigated in both studies. The article discusses the mechanisms of soluble receptor formation: 1) proteolytic cleavage of existing membrane receptors; 2) synthesis and release of soluble receptors lacking a transmembrane domain via alternative mRNA splicing; 3) release of membrane receptors in exosomes. Possible functional effects of soluble receptors are considered, i.e., neutralization of corresponding ligands (decoy receptors), ligand transport, ligand stabilization, and binding of membrane proteins. The results of studies of soluble receptors in health and disease are sometimes contradictory and not fully understood. Soluble receptors may be considered prospective therapeutic agents. Our previous data concerning probable functions of a number of soluble Tas2R38, Tas2R31, Tas2R5 receptors are considered when studying the patients with asthma in view of earlier knowledge of the soluble receptors functioning. The most important characteristics of the soluble receptors studied in BA are: 1) lower plasma levels of all discussed Tas2Rs in allergic asthma compared to nonallergic forms; 2) an inverse correlation between plasma Tas2R levels and bronchial resistance; 3) correlation of Tas2Rs with monocyte-macrophages, granulocytes and bronchial ciliated cells. The regulatory role of soluble receptors involved in asthma pathogenesis, mainly cytokines, as well as sTas2R and sRAGE, can be viewed through the corresponding membrane receptor functions. In this case, soluble forms of receptors play the role of decoy proteins that block functions mediated by membrane receptors. In this approach, the discussed soluble cytokine receptors and sRAGE have a positive regulatory effect in BA, whereas sTas2R exert negative action. The balance of soluble and membrane-bound receptor functions in cells involved in asthma pathogenesis is crucial for developing the novel therapies for asthma by targeting the Tas2R and RAGE receptors.


  • Soluble receptor for advanced glycation end products in patients with asthma

    by L. N. Sorokina, A. S. Pavlova, V. N. Mineev, V. I. Trofimov

      The Receptor for Advanced Glycation end Products (RAGE) is involved in the pathogenesis of a wide range of diseases, including those unrelated to disorders of carbohydrate metabolism. The soluble Receptor for Advanced Glycation end Products (sRAGE) is often considered as a decoy for RAGE ligands, thus preventing signal transmission into the cell and the realization of biological effects in different cell types. Research data has been accumulated about the possible role of RAGE in the pathogenesis of asthma. The aim was to look into sRAGE levels in patients with asthma compared with groups with a combination of asthma and type 2 diabetes mellitus (DM2), DM2 only, as well as the control group. Methods. There were a group of patients with asthma (n = 20), a group with DM2 (n = 17), a group with a combination of asthma and DM2 (n = 14), and a control group (n = 21). The level of glycated hemoglobin was determined by the method of immunoinhibition. Enzyme immunoassay was used to assess the levels of sRAGE, IL-4, and IFN-γ in blood serum. Pulmonary function tests included spirometry with a bronchodilation test, body plethysmometry, assessment of the diffusion capacity of the lungs during respiratory retention, assessment of the acid-base state and blood gases. Statistical data processing was performed using SPSS software for Windows (version 26.0). Results. Patients with allergic asthma had significantly lower (p < 0.001) sRAGE levels compared with non-allergic asthma, the control group, the group with a combination of asthma and DM2, as well as the group of patients with DM2. There was a significant negative correlation between sRAGE and IL-4 levels in patients with asthma. Statistically significant inverse correlations between the levels of sRAGE and IFN-γ were revealed in patients with asthma and patients with a combination of asthma and DM2. Significant correlations between the level of sRAGE and indicators of bronchopulmonary function have been demonstrated. Conclusion. The results of this study showed lower levels of sRAGE in patients with allergic asthma compared with nonallergic asthma and control group, the presence of significant correlations between sRAGE and indicators of pulmonary function tests.


  • Open Access

    TAS2R as components of the pathogenesis of respiratory diseases

    by R. G. Murkina, M. A. Nyoma, V. N. Mineev

    The present work investigates the role of ectopic bitter taste receptors (TAS2R) in the pathogenesis of respiratory diseases. Data are provided on the mechanism of G-protein-mediated signal transduction from taste receptors. Participation of TAS2R in the local protective mechanisms in a ciliated epithelium of the respiratory tract and its activation by «quorum sensing» system molecules and its connection with the components of mucociliary clearance are presented. In addition, TAS2R receptors are also considered to be associated with allergic diseases, in particular – with bronchial asthma.

  • The TAS2R receptor signaling system – view of asthmologist

    by V. N. Mineev, M. A. Nyoma, R. G. Murkina

    Since 2010, studies have been published that have found expression of bitter taste receptors Tas2R (the so-called extralingual or ectopic) on bronchial smooth muscle cells, and then on many other cells outside their canonical localization, in particular, on inflammatory cells. It was found that activation of Tas2R receptors, contrary to the bronchoconstrictor effect initially expected by the authors, led to more pronounced (3 times) bronchodilation than activation by β2-agonists. Over the past 15 years since the discovery of ectopic expression of Tas2R receptors in the respiratory system, a number of research areas have emerged and are developing in this new field of bronchial asthma research. These areas include: I – study of the expression of Tas2R receptor subtypes on bronchial smooth muscle; II – studies of the molecular mechanisms of Tas2R-signaling; III – studies of Tas2R receptor expression on respiratory system cells (ciliated epithelium) and on cells involved in allergic inflammation (lymphocytes, mast cells, macrophages, etc.); IV – studies of Tas2R gene polymorphisms and their association with predisposition to bronchial asthma; V – studies of the role of soluble Tas2R receptors in bronchial asthma; VI – search for opportunities to use Tas2R receptor activation for targeted therapy of bronchial asthma. The review examines the main positions of research areas in the field of Tas2R-signaling in bronchial asthma and provides the main literature in this area. Despite the achievements in the treatment of bronchial asthma, it is known that control over the disease cannot always be achieved completely. It is concluded that, given the versatility of the effects of tas2r receptors in bronchial asthma (bronchodilation, decreased activity of allergic inflammation and bronchial hyperreactivity, effects on remodeling), these receptors are a promising candidate for the development of comprehensive therapy for bronchial asthma.


  • Open Access

    Эктопические вкусовые рецепторы Tas2R1 к горькому вкусу в сыворотке крови при различных вариантах бронхиальной астмы

    by Михаил Александрович Нёма, Рахиль Геннадьевна Муркина, Лада Николаевна Сорокина, Валерий Николаевич Минеев

    Введение. В последние годы внимание исследователей привлечено к роли так называемых эктопических, расположенных вне канонической локализации, вкусовых рецепторов, в частности к горькому вкусу (Tas2R), в регуляции клеточных функций при бронхиальной астме (БА). Цель исследования — провести анализ ассоциации плазменных уровней Tas2R1 с клинико-функциональными характеристиками различных вариантов БА. Материалы и методы. Обследовано 10 практически здоровых лиц, 36 больных с аллергической БА (АБА) и 20 больных с неаллергической БА (НАБА). Уровень экспрессии Tas2R1 в сыворотке крови определяли иммуноферментным методом. Результаты. Уровни экспрессии рецепторов к горькому вкусу Tas2R1 в сыворотке крови при различных вариантах БА существенно различаются. При НАБА экспрессия Tas2R1 значимо выше, чем при АБА. Обнаружена при АБА прямая корреляционная связь Tas2R1 с содержанием нейтрофилов и обратная при НАБА — с количеством моноцитов в периферической крови. При этом связь Tas2R1 с количеством моноцитов в мокроте имеет позитивный характер при АБА. При НАБА как содержание макрофагов, так и бронхиального эпителия прямо коррелирует с уровнем Tas2R1. При АБА обнаружена прямая связь рецептора Tas2R1 со STAT6, STAT4, SOCS1, SOCS3. Выявлена прямая корреляционная связь уровня рецептора Tas2R1 с сопротивлением дыхательных путей. Обсуждение. B целом было выявлено, что экспрессия Tas2R1 в сыворотке крови при различных вариантах БА существенно различается, а именно при НАБА она значимо выше, чем при АБА. При АБА выявлена пре­имущественная корреляционная зависимость рецептора Tas2R1 от негативного регулятора SOCS1. Выводы. При корреляционном анализе связей уровней Tas2R1 при различных вариантах БА выявлены особенности, касающиеся связей с клеточным составом периферической крови и мокроты, а также с транскрипционными факторами, регулирующими аллергическое воспаление. Introduction. In recent years, the attention of researchers has been drawn to the role of so-called ectopic taste receptors, located outside the canonical localization, in particular bitter taste receptors (Tas2R), in the regulation of cellular functions in bronchial asthma (BA). The aim of the study was to analyze the association of plasma levels of Tas2R1 with clinical and functional characteristics of different variants of BA. Materials and methods. Ten practically healthy individuals, 36 patients with allergic BA (ABA) and 20 patients with non-allergic BA (NABA) were examined. The level of Tas2R1 expression in the blood serum was determined by the enzyme immunoassay. Results. The blood plasma levels of bitter taste receptors Tas2R1 in different variants of BA differ significantly. In NABA, this level is significantly higher than in ABA. A direct correlation between Tas2R1 and the neutrophil content was found in ABA, and an inverse correlation with the number of monocytes in the peripheral blood in NABA. The relationship between Tas2R1 and the number of monocytes in sputum is positive in ABA. In NABA, both the content of macrophages and bronchial epithelium directly correlates with the level of Tas2R1. In ABA, a direct relationship between the Tas2R1 receptor and STAT6, STAT4, SOCS1, SOCS3 was found. A direct correlation between the level of the Tas2R1 receptor and airway resistance was revealed. Discussion. In general, it was found that the levels of the Tas2R1 receptor in blood plasma in different variants of BA differ significantly, namely, in NABA this level is significantly higher than in ABA. In ABA, a predominant correlation dependence of the Tas2R1 receptor on the negative regulator SOCS1 was revealed. Conclusions. Correlation analysis of Tas2R1 levels in different variants of BA revealed features related to the correlation with the cellular composition of peripheral blood and sputum, as well as with transcription factors regulating allergic inflammation.


  • Open Access

    Circadian rhythms in some nephrological diseases

    by V. N. Mineev, D. I. Mamedova

    By now, it is well known that the circadian clock is an evolutionarily preserved mechanism that adapts the physiological processes of the body to circadian cycles. Circadian rhythms of kidney function are an integral part of kidney physiology.The most well-known general data on the mechanism of the circadian clock, as well as the features of the course of some nephrological diseases in terms of circadian rhythms, are briefly considered.It has to be stated that there are very few studies on the effect of circadian rhythms on the course of kidney disease, especially clinical studies.

  • Open Access

    АССОЦИАЦИЯ ПЛАЗМЕННЫХ УРОВНЕЙ ЭКТОПИЧЕСКОГО ВКУСОВОГО РЕЦЕПТОРА TAS2R5 С КЛИНИКО-ФУНКЦИОНАЛЬНЫМИ ХАРАКТЕРИСТИКАМИ БРОНХИАЛЬНОЙ АСТМЫ

    by Михаил Александрович Нёма, Валерий Николаевич Минеев, Рахиль Геннадьевна Муркина, Виктория Валериевна Садовая

    Введение. Накоплены данные о роли так называемых эктопических, расположенных вне канонической локализации, вкусовых рецепторов, в частности к горькому вкусу (TAS2R), в регуляции клеточных функций при бронхиальной астме (БА). Субтип рецепторов TAS2R5 считается одним из доминантных субтипов, опосредующих бронходилатацию. Цель исследования — провести анализ ассоциации плазменных уровней вкусового рецептора TAS2R5 с клинико-функциональными характеристиками различных вариантов БА. Материалы и методы. Обследовано 8 практически здоровых лиц, 39 больных с аллергической БА (АБА) и 19 больных с неаллергической БА (НАБА). Уровень экспрессии TAS2R5 в сыворотке крови определяли иммуноферментным методом в парных образцах при спектрофотометрии с длиной волны 450 нм. Результаты. Уровни рецепторов к горькому вкусу TAS2R5 в плазме крови при различных вариантах БА существенно различаются. При НАБА этот уровень достоверно выше, чем при АБА. При проведении факторного анализа выделено три фактора, выявляющих в целом позитивную связь компоненты плазменных уровней рецептора TAS2R5 с компонентами, характеризующими неаллергический вариант БА. С помощью корреляционного анализа выявлена негативная связь плазменных уровней TAS2R5 с индексом Тиффно. Обсуждение. Полученные данные о том, что плазменные уровни рецептора TAS2R5 имеют отрицательную корреляционную зависимость от показателя, характеризующего бронхиальную проходимость при БА, сопоставимы с результатами исследования рецептора TAS2R31. Сходная негативная корреляционная связь растворимых рецепторов (TAS2R5 и TAS2R31) с бронхиальной проходимостью позволяет предположить их одинаковый патогенетический механизм при БА — связывание лиганда с соответствующим растворимым рецептором и предотвращение доступности лигандов для контакта с мембранными рецепторами. Выводы. Обнаружена отрицательная корреляционная связь TAS2R5 с показателем, выявляющим бронхиальную обструкцию при БА (индекс Тиффно). Факторный анализ показал позитивную связь компоненты TAS2R5 с компонентами неаллергического варианта БА и сопутствующего сахарного диабета. Introduction. Evidence has accumulated on the role of so-called ectopic taste receptors, located outside the canonical localization, in particular to bitter taste (TAS2R), in the regulation of cellular functions in bronchial asthma (BA). The TAS2R5 receptor subtype is considered one of the dominant subtypes mediating bronchodilation. The aim of the study was to analyze the association of plasma levels of TAS2R5 taste receptor with clinical and functional characteristics of different variants of BA. Materials and methods. Eight practically healthy individuals, 39 patients with allergic BA (ABA) and 19 patients with non-allergic BA (NABA) were examined. The level of TAS2R5 expression in serum was determined by enzyme immunoassay in paired samples by spectrophotometry at a wavelength of 450 nm. Results. Levels of receptors to bitter taste TAS2R5 in blood plasma in different variants of BA differ significantly. In NABA this level is significantly higher than in ABA. The factor analysis revealed 3 factors revealing, in general, a positive relationship between the components of plasma levels of TAS2R5 receptor and the components characterizing the non-allergic variant of BA. Correlation analysis revealed a negative association of plasma levels of TAS2R5 with the Tiffeneau index. Discussion. The data obtained that plasma levels of TAS2R5 receptor have a negative correlation dependence on the index characterizing bronchial obstruction in BA are comparable with the results of the study of TAS2R31 receptor. A similar negative correlation between soluble receptors (TAS2R5 and TAS2R31) and bronchial obstruction suggests that they have the same pathogenetic mechanism in bronchial asthma — binding of the ligand to the corresponding soluble receptor and preventing the availability of ligands for contact with membrane receptors. Conclusions. A negative correlation was found between TAS2R5 and an indicator that identifies bronchial obstruction in bronchial asthma (Tiffeneau index). Factor analysis revealed a positive relationship between the TAS2R5 component and components of the non-allergic variant of bronchial asthma and concomitant diabetes mellitus.